Tau phosphorylation affects its axonal transport and degradation

Neurobiology of Aging

Volumn 34, Issue 9, 2013, Pages 2146-2157

  Rodríguez Martín, Teresa ^a   Cuchillo Ibáñez, Inmaculada ^a,b   Noble, Wendy ^a   Nyenya, Fanon ^a   Anderton, Brian H ^a   Hanger, Diane P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Axonal transport; Degradation; Tau phosphorylation

Indexed keywords

KINESIN 1; PROTEASOME; TAU PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; BIOACCUMULATION; CONTROLLED STUDY; EMBRYO; ENZYME DEGRADATION; FEMALE; IN VITRO STUDY; MOUSE; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RAT;

ALZHEIMER DISEASE; ANIMALS; AUTOPHAGY; AXONAL TRANSPORT; CHO CELLS; CRICETINAE; CRICETULUS; FIBROBLASTS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; RATS; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84878945608     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.03.015     Document Type: Article

References (84)

1. Ackerley S., Thornhill P., Grierson A.J., Brownlees J., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J.Cell Biol. 2003, 161:489-495.
2. Aplin A., Jasionowski T., Tuttle D.L., Lenk S.E., Dunn W.A. Cytoskeletal elements are required for the formation and maturation of autophagic vacuoles. J.Cell Physiol. 1992, 152:458-466.
3. Avila J., Leon-Espinosa G., Garcia E., Garcia-Escudero V., Hernandez F., Defelipe J. Tau phosphorylation by GSK3 in different conditions. Int. J. Alzheimers Dis. 2012, 2012:578373.
4. Ballatore C., Lee V.M., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8:663-672.
5. Bauereis B., Haskins W.E., Lebaron R.G., Renthal R. Proteomic insights into the protective mechanisms of an invitro oxidative stress model of early stage Parkinson's disease. Neurosci. Lett. 2011, 488:11-16.
6. Berger Z., Ravikumar B., Menzies F.M., Oroz L.G., Underwood B.R., Pangalos M.N., Schmitt I., Wullner U., Evert B.O., O'Kane C.J., Rubinsztein D.C. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 2006, 15:433-442.
7. Biasini E., Fioriti L., Ceglia I., Invernizzi R., Bertoli A., Chiesa R., Forloni G. Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells. J.Neurochem. 2004, 88:545-553.
8. Blommaart E.F., Krause U., Schellens J.P., Vreeling-Sindelarova H., Meijer A.J. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 1997, 243:240-246.
9. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993, 10:1089-1099.
10. Brandt R., Leger J., Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J.Cell Biol. 1995, 131:1327-1340.
11. Brown M.R., Bondada V., Keller J.N., Thorpe J., Geddes J.W. Proteasome or calpain inhibition does not alter cellular tau levels in neuroblastoma cells or primary neurons. J.Alzheimers Dis. 2005, 7:15-24.
12. Busciglio J., Lorenzo A., Yeh J., Yankner B.A. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995, 14:879-888.
13. Combs B., Voss K., Gamblin T.C. Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms. Biochemistry 2011, 50:9446-9456.
14. Congdon E.E., Wu J.W., Myeku N., Figueroa Y.H., Herman M., Marinec P.S., Gestwicki J.E., Dickey C.A., Yu W.H., Duff K.E. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy invitro and invivo. Autophagy 2012, 8:609-622.
15. Cuchillo-Ibanez I., Seereeram A., Byers H.L., Leung K.Y., Ward M.A., Anderton B.H., Hanger D.P. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J. 2008, 22:3186-3195.
16. Cuervo A.M. The plasma membrane brings autophagosomes to life. Nat. Cell Biol. 2010, 12:735-737.
17. Dann S.G., Selvaraj A., Thomas G. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 2007, 13:252-259.
18. David D.C., Layfield R., Serpell L., Narain Y., Goedert M., Spillantini M.G. Proteasomal degradation of tau protein. J.Neurochem. 2002, 83:176-185.
19. Davis D.R., Brion J.P., Couck A.M., Gallo J.M., Hanger D.P., Ladhani K., Lewis C., Miller C.C., Rupniak T., Smith C. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem. J. 1995, 309:941-949.
20. Delobel P., Leroy O., Hamdane M., Sambo A.V., Delacourte A., Buee L. Proteasome inhibition and tau proteolysis: an unexpected regulation. FEBS Lett. 2005, 579:1-5.
21. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008, 31:151-173.
22. de Vrij F.M., Fischer D.F., van Leeuwen F.W., Hol E.M. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog. Neurobiol. 2004, 74:249-270.
23. Ding H., Matthews T.A., Johnson G.V. Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation. J.Biol. Chem. 2006, 281:19107-19114.
24. Dolan P.J., Johnson G.V. Acaspase cleaved form of tau is preferentially degraded through the autophagy pathway. J.Biol. Chem. 2010, 285:21978-21987.
25. Du Y., Yang D., Li L., Luo G., Li T., Fan X., Wang Q., Zhang X., Wang Y., Le W. An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity. Autophagy 2009, 5:663-675.
26. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J.Cell Biol. 1998, 143:777-794.
27. Eidenmuller J., Fath T., Maas T., Pool M., Sontag E., Brandt R. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem. J. 2001, 357:759-767.
28. Falzone T.L., Gunawardena S., McCleary D., Reis G.F., Goldstein L.S. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies. Hum. Mol. Genet. 2010, 19:4399-4408.
29. Feuillette S., Blard O., Lecourtois M., Frebourg T., Campion D., Dumanchin C. Tau is not normally degraded by the proteasome. J.Neurosci. Res. 2005, 80:400-405.
30. Gallo J.M., Noble W., Martin T.R. RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies. Cell Mol. Life Sci. 2007, 64:1701-1714.
31. Gauthier-Kemper A., Weissmann C., Golovyashkina N., Sebo-Lemke Z., Drewes G., Gerke V., Heinisch J.J., Brandt R. The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner. J.Cell Biol. 2011, 192:647-661.
32. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526.
33. Hamano T., Gendron T.F., Ko L.W., Yen S.H. Concentration-dependent effects of proteasomal inhibition on tau processing in a cellular model of tauopathy. Int. J. Clin. Exp. Pathol. 2009, 2:561-573.
34. Hanger D.P., Anderton B.H., Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 2009, 15:112-119.
35. Hanger D.P., Byers H.L., Wray S., Leung K.Y., Saxton M.J., Seereeram A., Reynolds C.H., Ward M.A., Anderton B.H. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J.Biol. Chem. 2007, 282:23645-23654.
36. Johnson G.V. Tau phosphorylation and proteolysis: insights and perspectives. J.Alzheimers Dis. 2006, 9:243-250.
37. Kanai Y., Takemura R., Oshima T., Mori H., Ihara Y., Yanagisawa M., Masaki T., Hirokawa N. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. J.Cell Biol. 1989, 109:1173-1184.
38. Kim S.I., Lee W.K., Kang S.S., Lee S.Y., Jeong M.J., Lee H.J., Kim S.S., Johnson G.V., Chun W. Suppression of autophagy and activation of glycogen synthase kinase 3beta facilitate the aggregate formation of tau. Korean J. Physiol. Pharmacol. 2011, 15:107-114.
39. Klappan A.K., Hones S., Mylonas I., Bruning A. Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity. Histochem. Cell Biol. 2012, 137:25-36.
40. Korolchuk V.I., Mansilla A., Menzies F.M., Rubinsztein D.C. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol. Cell 2009, 33:517-527.
41. Korolchuk V.I., Menzies F.M., Rubinsztein D.C. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 2010, 584:1393-1398.
42. Kruger U., Wang Y., Kumar S., Mandelkow E.M. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol. Aging 2012, 33:2291-2305.
43. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., Ohsumi Y., Tokuhisa T., Mizushima N. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
44. Langkopf A., Guilleminot J., Nunez J. Tau and microtubule-associated protein 2c transfection and neurite outgrowth in ND 7/23 cells. J.Neurochem. 1995, 64:1045-1053.
45. Lawrence B.P., Brown W.J. Inhibition of protein synthesis separates autophagic sequestration from the delivery of lysosomal enzymes. J.Cell Sci. 1993, 105:473-480.
46. Lee G., Rook S.L. Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J.Cell Sci. 1992, 102:227-237.
47. Leger J., Kempf M., Lee G., Brandt R. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J.Biol. Chem. 1997, 272:8441-8446.
48. Li L., Zhang X., Le W. Autophagy dysfunction in Alzheimer's disease. Neurodegener. Dis. 2010, 7:265-271.
49. Liu Y.H., Wei W., Yin J., Liu G.P., Wang Q., Cao F.Y., Wang J.Z. Proteasome inhibition increases tau accumulation independent of phosphorylation. Neurobiol. Aging 2009, 30:1949-1961.
50. Ma D., Himes B.T., Shea T.B., Fischer I. Axonal transport of microtubule-associated protein 1B (MAP1B) in the sciatic nerve of adult rat: distinct transport rates of different isoforms. J.Neurosci. 2000, 20:2112-2120.
51. Maday S., Wallace K.E., Holzbaur E.L. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J.Cell Biol. 2012, 196:407-417.
52. Mandelkow E.M., Stamer K., Vogel R., Thies E., Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol. Aging 2003, 24:1079-1085.
53. Martinez-Vicente M., Cuervo A.M. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol. 2007, 6:352-361.
54. Petiot A., Ogier-Denis E., Blommaart E.F., Meijer A.J., Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J.Biol. Chem. 2000, 275:992-998.
55. Pooler A.M., Hanger D.P. Functional implications of the association of tau with the plasma membrane. Biochem. Soc. Trans. 2010, 38:1012-1015.
56. Pooler A.M., Usardi A., Evans C.J., Philpott K.L., Noble W., Hanger D.P. Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol. Aging 2012, 33:431-438.
57. Poppek D., Keck S., Ermak G., Jung T., Stolzing A., Ullrich O., Davies K.J., Grune T. Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem. J. 2006, 400:511-520.
58. Ravikumar B., Moreau K., Rubinsztein D.C. Plasma membrane helps autophagosomes grow. Autophagy 2010, 6:1184-1186.
59. Renna M., Jimenez-Sanchez M., Sarkar S., Rubinsztein D.C. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J.Biol. Chem. 2010, 285:11061-11067.
60. Riederer B.M., Leuba G., Vernay A., Riederer I.M. The role of the ubiquitin proteasome system in Alzheimer's disease. Exp. Biol. Med. (Maywood) 2011, 236:268-276.
61. Sadasivan S., Zhang Z., Larner S.F., Liu M.C., Zheng W., Kobeissy F.H., Hayes R.L., Wang K.K. Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype. BMC Neurosci. 2010, 11:21.
62. Sarkar S., Rubinsztein D.C. Huntington's disease: degradation of mutant huntingtin by autophagy. FEBS J. 2008, 275:4263-4270.
63. Schaeffer V., Lavenir I., Ozcelik S., Tolnay M., Winkler D.T., Goedert M. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 2012, 135:2169-2177.
64. Scott C.W., Klika A.B., Lo M.M., Norris T.E., Caputo C.B. Tau protein induces bundling of microtubules invitro: comparison of different tau isoforms and a tau protein fragment. J.Neurosci. Res. 1992, 33:19-29.
65. Shacka J.J., Roth K.A., Zhang J. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy. Front. Biosci. 2008, 13:718-736.
66. Smith M.J., Crowther R.A., Goedert M. The natural osmolyte trimethylamine N-oxide (TMAO) restores the ability of mutant tau to promote microtubule assembly. FEBS Lett. 2000, 484:265-270.
67. Stoothoff W.H., Bacskai B.J., Hyman B.T. Monitoring tau-tubulin interactions utilizing second harmonic generation in living neurons. J.Biomed. Opt. 2008, 13:064039.
68. Tai H.C., Schuman E.M. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat. Rev. Neurosci. 2008, 9:826-838.
69. Takemura R., Okabe S., Umeyama T., Kanai Y., Cowan N.J., Hirokawa N. Increased microtubule stability and alpha tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J.Cell Sci. 1992, 103:953-964.
70. Thorn K.S., Ubersax J.A., Vale R.D. Engineering the processive run length of the kinesin motor. J.Cell Biol. 2000, 151:1093-1100.
71. Usardi A., Pooler A.M., Seereeram A., Reynolds C.H., Derkinderen P., Anderton B., Hanger D.P., Noble W., Williamson R. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS J. 2011, 278:2927-2937.
72. Utton M.A., Noble W.J., Hill J.E., Anderton B.H., Hanger D.P. Molecular motors implicated in the axonal transport of tau and alpha-synuclein. J.Cell Sci. 2005, 118:4645-4654.
73. Utton M.A., Vandecandelaere A., Wagner U., Reynolds C.H., Gibb G.M., Miller C.C., Bayley P.M., Anderton B.H. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem. J. 1997, 323:741-747.
74. Wagner U., Utton M., Gallo J.M., Miller C.C. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J.Cell Sci. 1996, 109:1537-1543.
75. Wang J.Y., Xia Q., Chu K.T., Pan J., Sun L.N., Zeng B., Zhu Y.J., Wang Q., Wang K., Luo B.Y. Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine: a widely used inhibitor of autophagy. J.Neuropathol. Exp. Neurol. 2011, 70:314-322.
76. Wang L., Ho C.L., Sun D., Liem R.K., Brown A. Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol. 2000, 2:137-141.
77. Wang Y., Kruger U., Mandelkow E., Mandelkow E.M. Generation of tau aggregates and clearance by autophagy in an inducible cell model of tauopathy. Neurodegener. Dis. 2010, 7:103-107.
78. Wang Y., Martinez-Vicente M., Kruger U., Kaushik S., Wong E., Mandelkow E.M., Cuervo A.M., Mandelkow E. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 2009, 18:4153-4170.
79. Webb J.L., Ravikumar B., Rubinsztein D.C. Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases. Int. J. Biochem. Cell Biol. 2004, 36:2541-2550.
80. Yamamoto A., Simonsen A. The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration. Neurobiol. Dis. 2011, 43:17-28.
81. Zhang J.Y., Liu S.J., Li H.L., Wang J.Z. Microtubule-associated protein tau is a substrate of ATP/Mg(2+)-dependent proteasome protease system. J.Neural Transm. 2005, 112:547-555.
82. Zhang J.Y., Peng C., Shi H., Wang S., Wang Q., Wang J.Z. Inhibition of autophagy causes tau proteolysis by activating calpain in rat brain. J.Alzheimers Dis. 2009, 16:39-47.
83. Zheng Q., Li J., Wang X. Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies. Int. J. Physiol. Pathophysiol. Pharmacol. 2009, 1:127-142.
84. Zheng Q., Su H., Tian Z., Wang X. Proteasome malfunction activates macroautophagy in the heart. Am. J. Cardiovasc. Dis. 2011, 1:214-226.